Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches

ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

Pulmonology

17 min

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Pulmonology

29 min

expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Gastroenterology

5 min

Infographic

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

Podcast

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Dermatology

42 min

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Benefits of Early Intervention in AD: More Than Skin Deep

Dermatology

82 min

expert video

The Benefits of Early Intervention in AD: More Than Skin Deep

Learning Hub

EoE Learning Hub

EoE is a chronic, progressive type 2 inflammatory disease marked by esophageal inflammation, remodeling, fibrosis, dysfunction, and food impaction. In adults, it presents as dysphagia, food impaction, and chest pain, while in children, it may show as nonspecific symptoms like abdominal pain, vomiting, food refusal, and failure to thrive.

Access the resources below to gain better understanding on a variety of topics related to EoE.

On demand event highlights

1 assets

Unlocking Better Outcomes: Strategies for Early Diagnosis and Effective Management in Pediatric EoE Patients

Pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.

9 assets

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

The March 2025 ADVENT symposium in Orlando, Florida brought together 4 dermatology experts to explore the evolving science of type 2 inflammation. Type 2 inflammation plays a central role in the pathophysiology of multiple dermatological diseases, driving chronic immune dysregulation that affects patients with atopic dermatitis (AD) prurigo nodularis (PN), chronic spontaneous urticaria (CSU) and bullous pemphigoid (BP). Understanding the mechanisms behind type 2 inflammation is key to advancing care and improving patient quality of life.

5 assets

Emerging Perspectives on the Disease Burden and Management of Children with Atopic Dermatitis

Join Christine Bangert and Perla Lansang for an educational symposium on atopic dermatitis (AD) in children, exploring the diagnosis and pathophysiology of AD in children, the life-long effects of uncontrolled disease beyond the skin, and current and emerging therapies.

Join Profs. Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller for an educational symposium exploring the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

2 assets

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

Highlights from the ADVENT educational symposium at EADV 2024 where Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.

Join experts Dedee Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational symposium on the clinical presentation, disease burden, diagnosis and pathophysiology of BP.

6 assets

Bullous Pemphigoid: Exploring New Frontiers

Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).

4 assets

ERS 2024 | Targeting IL-33 in COPD: Exploring New Frontiers for COPD Management

Professors Klaus Rabe, Paola Rogliani, and Dr. Stephanie Christenson explore the complexity of inflammatory pathways and phenotypes in COPD. They provide insights into the genetic association of IL-33 with COPD, and discuss preclinical findings.

3 assets

ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz and Mona Bafadhel for an educational symposium exploring the role of type 2 cytokines in COPD and delve into the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden.

3 assets

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

1 assets

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

2 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

2 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

3 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Drs Sarina Elmariah and Mona Shahriari discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncover how clinical signs and itch in these diseases are impacted by type 2 inflammation.

10 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

The following materials review the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient, improving clinical management and reducing long-term patient burden.

1 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of biomarker assessments in guiding management strategies of recognizing the heterogeneity of COPD.

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

Join Drs. James Del Rosso and Raj Chovatiya for an education program to explore the impact, contribution, and diagnosis of type 2 inflammation on atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

1 assets